The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
Open accessAbstract
OBJECTIVE: To estimate the risk and prevalence of Mycobacterium tuberculosis (MTB) infection and tuberculosis (TB) incidence, prevalence, and mortality, including disease attributable to human immunodeficiency virus (HIV), for 212 countries in 1997. PARTICIPANTS: A panel of 86 TB experts and epidemiologists from more than 40 countries was chosen by the World Health Organization (WHO), with final agreement being reached between country experts and WHO staff. EVIDENCE: Incidence of TB and mortality in each country was determined by (1) case notification to the WHO, (2) annual risk of infection data from tuberculin surveys, and (3) data on prevalence of smear-positive pulmonary disease from prevalence surveys. Estimates derived from relatively poor data were strongly influenced by panel member opinion. Objective estimates were derived from high-quality data collected recently by approved procedures. CONSENSUS PROCESS: Agreement was reached by (1) participants reviewing methods and data and making provisional estimates in closed workshops held at WHO's 6 regional offices, (2) principal authors refining estimates using standard methods and all available data, and (3) country experts reviewing and adjusting these estimates and reaching final agreement with WHO staff. CONCLUSIONS: In 1997, new cases of TB totaled an estimated 7.96 million (range, 6.3 million-11.1 million), including 3.52 million (2.8 million-4.9 million) cases (44%) of infectious pulmonary disease (smear-positive), and there were 16.2 million (12.1 million-22.5 million) existing cases of disease. An estimated 1.87 million (1.4 million-2.8 million) people died of TB and the global case fatality rate was 23% but exceeded 50% in some African countries with high HIV rates. Global prevalence of MTB infection was 32% (1.86 billion people). Eighty percent of all incident TB cases were found in 22 countries, with more than half the cases occurring in 5 Southeast Asian countries. Nine of 10 countries with the highest incidence rates per capita were in Africa. Prevalence of MTB/HIV coinfection worldwide was 0.18% and 640000 incident TB cases (8%) had HIV infection. The global burden of tuberculosis remains enormous, mainly because of poor control in Southeast Asia, sub-Saharan Africa, and eastern Europe, and because of high rates of M tuberculosis and HIV coinfection in some African countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Edlin, B. R., Tokars, J. I., Grieco, M. H., Crawford, J. T., Williams, J., Sordillo, E. M., Ong, K. R., Kilburn, J. O., Dooley, S. W., Castro, K. G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206043262302 · Cited by 861
Global tuberculosis incidence and mortality during 1990-2000.
Pj, D., Raviglione, M. C., & Kochi, A. (1994) · PubMed · Cited by 768
Self-citationTuberculosis: a global overview of the situation today.
Sudre, P., ten Dam, G., & Kochi, A. (1992) · Europe PMC (PubMed Central) · Cited by 539
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
Dye, C., Garnett, G. P., Sleeman, K., & Williams, B. G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03199-7 · Cited by 462
Self-citationWorld Development Report 1992.
Bank, W. (1992) · Population and Development Review · doi:10.2307/1973669 · Cited by 354
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470110027006 · Cited by 272
Coronado, V. G., Beck-Sague, C. M., Hutton, M. D., Davis, B. J., Nicholas, P., Villareal, C., Woodley, C. L., Kilburn, J. O., Crawford, J. T., Frieden, T. R., et al. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/168.4.1052 · Cited by 200
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
Shafer, R. W., & Edlin, B. R. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.683 · Cited by 174
Cited by
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Self-citationGutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
Houben, R. M. G. J., & Dodd, P. J. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002152 · Cited by 2,054
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,162
Syndemics and public health: Reconceptualizing disease in bio-social context
Singer, M., & Clair, S. (2003) · Medical Anthropology Quarterly · doi:10.1525/maq.2003.17.4.423 · Cited by 1,140
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Self-citationA small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
A systematic review of delay in the diagnosis and treatment of tuberculosis
Storla, D. G., Yimer, S., & Bjune, G. A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-15 · Cited by 1,018
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
Pai, M., Riley, L. W., & Colford, J. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01206-x · Cited by 913
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70189-4 · Cited by 851
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Vitamin D3 Induces Autophagy in Human Monocytes/Macrophages via Cathelicidin
Yuk, J.-M., Shin, D.-M., Lee, H.-M., Yang, C.-S., Jin, H. S., Kim, K.-K., Lee, Z.-W., Lee, S.-H., Kim, J.-M., & Jo, E.-K. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.08.004 · Cited by 787
Tuberculosis and HIV Co-Infection
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002464 · Cited by 764
Gardam, M. A., Keystone, E. C., Menzies, R., Manners, S., Skamene, E., Long, R., & Vinh, D. C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00545-0 · Cited by 752
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., De Munter, P., D'Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., et al. (2009) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.02.010 · Cited by 738
Global epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 716
Self-citationTreatment of latent tuberculosis infection in HIV infected persons
Akolo, C., Adetifa, I., Shepperd, S., & Volmink, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000171.pub3 · Cited by 713
Park, H., Guinn, K. M., Harrell, M. I., Liao, R., Voskuil, M. I., Tompa, M., Schoolnik, G. K., & Sherman, D. R. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03474.x · Cited by 712
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Mycobacterium tuberculosis: success through dormancy
Gengenbacher, M., & Kaufmann, S. H. E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00331.x · Cited by 696
Intraocular Tuberculosis—An Update
Gupta, V., Gupta, A., & Rao, N. A. (2007) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2007.08.015 · Cited by 680
The double burden of communicable and non-communicable diseases in developing countries
Boutayeb, A. (2006) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.07.021 · Cited by 672
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Self-citationGlickman, M. S., Cox, J. S., & Jacobs, W. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80250-6 · Cited by 655
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
Comprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616
Stanley, S. A., Raghavan, S., Hwang, W. W., & Cox, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235593100 · Cited by 570
Getahun, H., Matteelli, A., Abubakar, I., Aziz, M. A., Baddeley, A., Barreira, D., Den Boon, S., Borroto Gutierrez, S. M., Bruchfeld, J., Burhan, E., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01245-2015 · Cited by 596
Self-citationSteingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70602-8 · Cited by 573
Persistent bacterial infections: the interface of the pathogen and the host immune system
Monack, D. M., Mueller, A., & Falkow, S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro955 · Cited by 572
The global prevalence of latent tuberculosis: A systematic review and meta-analysis
Cohen, A., Mathiasen, V. D., Schön, T., & Wejse, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00655-2019 · Cited by 547
Characterizing exhaled airflow from breathing and talking
Gupta, J. K., Lin, C.-H., & Chen, Q. (2010) · Indoor Air · doi:10.1111/j.1600-0668.2009.00623.x · Cited by 564
Badri, M., Wilson, D., & Wood, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08904-3 · Cited by 556
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities
Parsons, L. M., Somoskövi, Á., Gutierrez, C., Lee, E., Paramasivan, C. N., Abimiku, A., Spector, S., Roscigno, G., & Nkengasong, J. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-10 · Cited by 540
Dye, C. (2005) · JAMA · doi:10.1001/jama.293.22.2767 · Cited by 534
Self-citationM. tuberculosis persistence, latency, and drug tolerance
Gomez, J. E., & McKinney, J. D. (2004) · Tuberculosis · doi:10.1016/j.tube.2003.08.003 · Cited by 533
Parish, T., & Stoker, N. G. (2000) · Microbiology · doi:10.1099/00221287-146-8-1969 · Cited by 512
Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest
Fratti, R. A., Chua, J., Vergne, I., & Deretic, V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737613100 · Cited by 508
Mycobacterium tuberculosis and the Macrophage: Maintaining a Balance
Pieters, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.05.006 · Cited by 503
Tuberculosis: Latency and Reactivation
Flynn, J. L., & Chan, J. (2001) · Infection and Immunity · doi:10.1128/iai.69.7.4195-4201.2001 · Cited by 500
Jasmer, R. M., Nahid, P., & Hopewell, P. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp021045 · Cited by 497
Rangaka, M. X., Wilkinson, K. A., Glynn, J. R., Ling, D., Menzies, D., Mwansa-Kambafwile, J., Fielding, K., Wilkinson, R. J., & Pai, M. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70210-9 · Cited by 476
Khader, S. A., Pearl, J. E., Sakamoto, K., Gilmartin, L., Bell, G. K., Jelley-Gibbs, D. M., Ghilardi, N., deSauvage, F., & Cooper, A. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.788 · Cited by 472
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 468
Alsdurf, H., Hill, P. C., Matteelli, A., Getahun, H., & Menzies, D. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30216-x · Cited by 459
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Troughton, R. W., Asher, C. R., & Klein, A. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15648-1 · Cited by 430
Rapid Detection of Mycobacterium tuberculosis Infection by Enumeration of Antigen-specific T Cells
LALVANI, A., PATHAN, A. A., McSHANE, H., WILKINSON, R. J., LATIF, M., CONLON, C. P., PASVOL, G., & HILL, A. V. S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2009100 · Cited by 427
Cytochrome P450 2E1 Genotype and the Susceptibility to Antituberculosis Drug–Induced Hepatitis
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Chang, S.-C., Chiang, C.-H., Chang, F.-Y., & Lee, S.-D. (2003) · Hepatology · doi:10.1053/jhep.2003.50144 · Cited by 426
Newton, S. M., Brent, A. J., Anderson, S., Whittaker, E., & Kampmann, B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70182-8 · Cited by 480
Evolutionary Causes and Consequences of Immunopathology
Graham, A. L., Allen, J. E., & Read, A. F. (2005) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev.ecolsys.36.102003.152622 · Cited by 417
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 413
A Single Dose of Vitamin D Enhances Immunity to Mycobacteria
Martineau, A. R., Wilkinson, R. J., Wilkinson, K. A., Newton, S. M., Kampmann, B., Hall, B. M., Packe, G. E., Davidson, R. N., Eldridge, S. M., Maunsell, Z. J., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-007oc · Cited by 408
The Secret Lives of the Pathogenic Mycobacteria
Cosma, C. L., Sherman, D. R., & Ramakrishnan, L. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.091033 · Cited by 407
Characterization and Transcriptome Analysis of Mycobacterium tuberculosis Persisters
Keren, I., Minami, S., Rubin, E., & Lewis, K. (2011) · mBio · doi:10.1128/mbio.00100-11 · Cited by 404
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection
Tufariello, J. M., Chan, J., & Flynn, J. L. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00741-2 · Cited by 403
Prospects for Tuberculosis Elimination
Dye, C., Glaziou, P., Floyd, K., & Raviglione, M. (2013) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114431 · Cited by 402
Self-citationLalvani, A., Pathan, A. A., Durkan, H., Wilkinson, K. A., Whelan, A., Deeks, J. J., Reece, W. H., Latif, M., Pasvol, G., & Hill, A. V. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05115-1 · Cited by 400
Stable association between strains of Mycobacterium tuberculosis and their human host populations
Hirsh, A. E., Tsolaki, A. G., DeRiemer, K., Feldman, M. W., & Small, P. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305627101 · Cited by 397
Tuberculosis: a problem with persistence
Stewart, G. R., Robertson, B. D., & Young, D. B. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro749 · Cited by 386
Global Epidemiology of Tuberculosis
Floyd, K., Raviglione, M., & Glaziou, P. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1651492 · Cited by 381
Self-citationAn essential role for phoP in Mycobacterium tuberculosis virulence
Pérez, E., Samper, S., Bordas, Y., Guilhot, C., Gicquel, B., & Martín, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02500.x · Cited by 379
Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis
Smith, N. H., Gordon, S. V., de la Rua-Domenech, R., Clifton-Hadley, R. S., & Hewinson, R. G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1472 · Cited by 375
Management of Tuberculosis in the United States
Small, P. M., & Fujiwara, P. I. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450307 · Cited by 372
Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803899200 · Cited by 364
The temporal expression profile of Mycobacterium tuberculosis infection in mice
Talaat, A. M., Lyons, R., Howard, S. T., & Johnston, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306023101 · Cited by 363
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 362
Wang, J., Thorson, L., Stokes, R. W., Santosuosso, M., Huygen, K., Zganiacz, A., Hitt, M., & Xing, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6357 · Cited by 359
Vitamin D in health and disease: Current perspectives
Zhang, R., & Naughton, D. P. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-65 · Cited by 358
The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis
Cooper, A. M., & Khader, S. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00702.x · Cited by 353
Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline
Glickman, M. S., & Jacobs, W. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00236-7 · Cited by 352
Lalvani, A., Nagvenkar, P., Udwadia, Z., Pathan, A. A., Wilkinson, K. A., Shastri, J. S., Ewer, K., Hill, A. V. S., Mehta, A., & Rodrigues, C. (2001) · The Journal of Infectious Diseases · doi:10.1086/318081 · Cited by 343
The paradox of matrix metalloproteinases in infectious disease
Elkington, P. T. G., O'Kane, C. M., & Friedland, J. S. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02840.x · Cited by 340
Pharmacokinetics-Pharmacodynamics of Rifampin in an Aerosol Infection Model of Tuberculosis
Jayaram, R., Gaonkar, S., Kaur, P., Suresh, B. L., Mahesh, B. N., Jayashree, R., Nandi, V., Bharat, S., Shandil, R. K., Kantharaj, E., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2118-2124.2003 · Cited by 335
Ancestral antibiotic resistance in Mycobacterium tuberculosis
Morris, R. P., Nguyen, L., Gatfield, J., Visconti, K., Nguyen, K., Schnappinger, D., Ehrt, S., Liu, Y., Heifets, L., Pieters, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505446102 · Cited by 333
Tuberculosis in HIV-infected patients: a comprehensive review
Aaron, L., Saadoun, D., Calatroni, I., Launay, O., Mémain, N., Vincent, V., Marchal, G., Dupont, B., Bouchaud, O., Valeyre, D., et al. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00758.x · Cited by 330
Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor
Kumar, A., Toledo, J. C., Patel, R. P., Lancaster, J. R., & Steyn, A. J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705054104 · Cited by 331
Prospective Study of One Million Deaths in India: Rationale, Design, and Validation Results
Jha, P., Gajalakshmi, V., Gupta, P. C., Kumar, R., Mony, P., Dhingra, N., Peto, R., & Collaborators, R.-C. P. S. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030018 · Cited by 323
Singh, A., Crossman, D. K., Mai, D., Guidry, L., Voskuil, M. I., Renfrow, M. B., & Steyn, A. J. C. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000545 · Cited by 326
The ongoing challenge of latent tuberculosis
Esmail, H., Barry, C. E., Young, D. B., & Wilkinson, R. J. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0437 · Cited by 325
Chapman, A. L., Munkanta, M., Wilkinson, K. A., Pathan, A. A., Ewer, K., Ayles, H., Reece, W. H., Mwinga, A., Godfrey-Faussett, P., & Lalvani, A. (2002) · AIDS · doi:10.1097/00002030-200211220-00008 · Cited by 319
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection
Simmons, J. D., Stein, C. M., Seshadri, C., Campo, M., Alter, G., Fortune, S., Schurr, E., Wallis, R. S., Churchyard, G., Mayanja-Kizza, H., et al. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0025-3 · Cited by 314
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Mukadi, Y. D., Maher, D., & Harries, A. (2001) · AIDS · doi:10.1097/00002030-200101260-00002 · Cited by 311
Lin, H.-H., Murray, M., Cohen, T., Colijn, C., & Ezzati, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61345-8 · Cited by 302
Quinoline: A promising antitubercular target
Keri, R. S., & Patil, S. A. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.007 · Cited by 301
A family of autocrine growth factors in Mycobacterium tuberculosis
Mukamolova, G. V., Turapov, O. A., Young, D. I., Kaprelyants, A. S., Kell, D. B., & Young, M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03184.x · Cited by 291
Rodrigues, L. C., Pereira, S. M., Cunha, S. S., Genser, B., Ichihara, M. Y., de Brito, S. C., Hijjar, M. A., Cruz, A. A., Sant'Anna, C., Bierrenbach, A. L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67145-0 · Cited by 286
Raman, S., Song, T., Puyang, X., Bardarov, S., Jacobs, W. R., & Husson, R. N. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.6119-6125.2001 · Cited by 283
Timm, J., Post, F. A., Bekker, L.-G., Walther, G. B., Wainwright, H. C., Manganelli, R., Chan, W.-T., Tsenova, L., Gold, B., Smith, I., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436197100 · Cited by 279
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness
Cohen, T., & Murray, M. (2004) · Nature Medicine · doi:10.1038/nm1110 · Cited by 277
Metadata
- Authors
- Dye, C., Scheele, S., >Dolin, P., Pathania, V., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-08-18
- Volume
- 282
- Issue
- 7
- Pages
- 677
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2157737997
- Cited by
- 2,947
- References
- 20
- FWCI
- 74.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.